These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2017530)

  • 1. Biological measures and cellular immunological function in depressed psychiatric inpatients.
    Levy EM; Borrelli DJ; Mirin SM; Salt P; Knapp PH; Peirce C; Fox BH; Black PH
    Psychiatry Res; 1991 Feb; 36(2):157-67. PubMed ID: 2017530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired mitogen-induced lymphocyte responses and the hypothalamic-pituitary-adrenal axis in depressive disorders.
    Cosyns P; Maes M; Vandewoude M; Stevens WJ; De Clerck LS; Schotte C
    J Affect Disord; 1989; 16(1):41-8. PubMed ID: 2521650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process.
    Maes M; Bosmans E; Suy E; Minner B; Raus J
    Br J Psychiatry; 1989 Dec; 155():793-8. PubMed ID: 2620206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorders.
    Anesi A; Franciotta D; Di Paolo E; Zardini E; Melzi d'Eril GV; Zerbi F
    Funct Neurol; 1994; 9(1):17-22. PubMed ID: 8082849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte function in major depressive disorder.
    Schleifer SJ; Keller SE; Meyerson AT; Raskin MJ; Davis KL; Stein M
    Arch Gen Psychiatry; 1984 May; 41(5):484-6. PubMed ID: 6609689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and immunity: age, severity, and clinical course.
    Andreoli AV; Keller SE; Rabaeus M; Marin P; Bartlett JA; Taban C
    Brain Behav Immun; 1993 Dec; 7(4):279-92. PubMed ID: 8280922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization.
    Schleifer SJ; Keller SE; Bond RN; Cohen J; Stein M
    Arch Gen Psychiatry; 1989 Jan; 46(1):81-7. PubMed ID: 2562915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune cell parameters in severely depressed patients: negative findings.
    Maes M; Bosmans E; Suy E; Minner B; Raus J
    J Affect Disord; 1989; 17(2):121-8. PubMed ID: 2527887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity in young adults with major depressive disorder.
    Schleifer SJ; Keller SE; Bartlett JA; Eckholdt HM; Delaney BR
    Am J Psychiatry; 1996 Apr; 153(4):477-82. PubMed ID: 8599394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte function in major depression.
    Altshuler LL; Plaeger-Marshall S; Richeimer S; Daniels M; Baxter LR
    Acta Psychiatr Scand; 1989 Aug; 80(2):132-6. PubMed ID: 2801161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced natural killer cell cytotoxicity in depression but not in schizophrenia.
    Caldwell CL; Irwin M; Lohr J
    Biol Psychiatry; 1991 Dec; 30(11):1131-8. PubMed ID: 1777529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bereavement, depression, and immune function.
    Zisook S; Shuchter SR; Irwin M; Darko DF; Sledge P; Resovsky K
    Psychiatry Res; 1994 Apr; 52(1):1-10. PubMed ID: 8047615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early nutrition support modifies immune function in patients sustaining severe head injury.
    Sacks GS; Brown RO; Teague D; Dickerson RN; Tolley EA; Kudsk KA
    JPEN J Parenter Enteral Nutr; 1995; 19(5):387-92. PubMed ID: 8577017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A further exploration of the relationships between immune parameters and the HPA-axis activity in depressed patients.
    Maes M; Bosmans E; Suy E; Minner B; Raus J
    Psychol Med; 1991 May; 21(2):313-20. PubMed ID: 1876636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity, major depression, and panic disorder comorbidity.
    Andreoli A; Keller SE; Rabaeus M; Zaugg L; Garrone G; Taban C
    Biol Psychiatry; 1992 May; 31(9):896-908. PubMed ID: 1637930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test.
    Lowy MT; Reder AT; Gormley GJ; Meltzer HY
    Biol Psychiatry; 1988 Oct; 24(6):619-30. PubMed ID: 3262379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of partial variance to control for day-to-day variability in functional immune tests in depression.
    Maes M; Thompson P
    Neuropsychobiology; 1997; 36(3):107-11. PubMed ID: 9313242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone.
    Lowy MT; Reder AT; Antel JP; Meltzer HY
    Am J Psychiatry; 1984 Nov; 141(11):1365-70. PubMed ID: 6333828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production.
    Maes M; Bosmans E; Suy E; Vandervorst C; DeJonckheere C; Raus J
    Acta Psychiatr Scand; 1991 Oct; 84(4):379-86. PubMed ID: 1746291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell activity in major depression: relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology.
    Maes M; Meltzer HY; Stevens W; Calabrese J; Cosyns P
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):717-30. PubMed ID: 7938562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.